2 results
Approved WMOCompleted
To assess the effects of dexamphetamine with and without alcohol on simulated driving performance.
Approved WMOCompleted
The primary objective is to assess the clinical efficacy of siltuximab (a chimeric (murine-human) IgG1* mAb that specifically binds human IL-6 with high affinity and prevents its interaction with the IL-6 receptor, glycoprotein (GP) 80),…